Skip to content
Studies have shown that active fund managers routinely underperform the S&P500 index*
Home
Articles
WALL STREET X
Forecasts
Portfolios
Wall Street X
Articles
Forecasts
Portfolios
Search
Results for
{phrase}
(
{results_count}
of
{results_count_total}
)
Displaying
{results_count}
results of
{results_count_total}
ProKidney Corp. (NASDAQ: PROK)
PROK Stock Predictions and Ratings
WSX Rating:
STRONG SELL
WSX Forecast (1yr):
-60%
Analyst Rating:
STRONG BUY
Analyst Forecast (1yr):
229.50%
PROK Stock Analysis
PROK
PE Ratio:
PROK
PEG Ratio:
Not Available
PROK
Forward EPS Growth (12 month):
0.00%
PROK
PS Ratio:
654.4
PROK
PSG Ratio:
-40.4
PROK
Forward Revenue Growth (12 month):
-16.20%
PROK Articles
No data was found